202 related articles for article (PubMed ID: 38379085)
21. LINC00037 Inhibits Proliferation of Renal Cell Carcinoma Cells in an Epidermal Growth Factor Receptor-Dependent Way.
Gong X; Du X; Xu Y; Zheng W
Cell Physiol Biochem; 2018; 45(2):523-536. PubMed ID: 29393141
[TBL] [Abstract][Full Text] [Related]
22. ZD1839 modulates paclitaxel response in renal cancer by blocking paclitaxel-induced activation of the epidermal growth factor receptor-extracellular signal-regulated kinase pathway.
Sumitomo M; Asano T; Asakuma J; Asano T; Horiguchi A; Hayakawa M
Clin Cancer Res; 2004 Jan; 10(2):794-801. PubMed ID: 14760103
[TBL] [Abstract][Full Text] [Related]
23. Von Hippel-Lindau tumor suppressor gene loss in renal cell carcinoma promotes oncogenic epidermal growth factor receptor signaling via Akt-1 and MEK-1.
Lee SJ; Lattouf JB; Xanthopoulos J; Linehan WM; Bottaro DP; Vasselli JR
Eur Urol; 2008 Oct; 54(4):845-53. PubMed ID: 18243508
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
[TBL] [Abstract][Full Text] [Related]
25. Cbl-mediated ubiquitinylation is required for lysosomal sorting of epidermal growth factor receptor but is dispensable for endocytosis.
Duan L; Miura Y; Dimri M; Majumder B; Dodge IL; Reddi AL; Ghosh A; Fernandes N; Zhou P; Mullane-Robinson K; Rao N; Donoghue S; Rogers RA; Bowtell D; Naramura M; Gu H; Band V; Band H
J Biol Chem; 2003 Aug; 278(31):28950-60. PubMed ID: 12754251
[TBL] [Abstract][Full Text] [Related]
26. Blocking the autocrine regulatory loop of Gankyrin/STAT3/CCL24/CCR3 impairs the progression and pazopanib resistance of clear cell renal cell carcinoma.
Wang C; Wang Y; Hong T; Cheng B; Gan S; Chen L; Zhang J; Zuo L; Li J; Cui X
Cell Death Dis; 2020 Feb; 11(2):117. PubMed ID: 32051393
[TBL] [Abstract][Full Text] [Related]
27. Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia.
Gunningham SP; Currie MJ; Han C; Turner K; Scott PA; Robinson BA; Harris AL; Fox SB
Cancer Res; 2001 Apr; 61(7):3206-11. PubMed ID: 11306510
[TBL] [Abstract][Full Text] [Related]
28. The ubiquitin-specific protease USP2a prevents endocytosis-mediated EGFR degradation.
Liu Z; Zanata SM; Kim J; Peterson MA; Di Vizio D; Chirieac LR; Pyne S; Agostini M; Freeman MR; Loda M
Oncogene; 2013 Mar; 32(13):1660-9. PubMed ID: 22710717
[TBL] [Abstract][Full Text] [Related]
29. Endocytic function of von Hippel-Lindau tumor suppressor protein regulates surface localization of fibroblast growth factor receptor 1 and cell motility.
Hsu T; Adereth Y; Kose N; Dammai V
J Biol Chem; 2006 Apr; 281(17):12069-80. PubMed ID: 16505488
[TBL] [Abstract][Full Text] [Related]
30. HSPA12A unstabilizes CD147 to inhibit lactate export and migration in human renal cell carcinoma.
Min X; Zhang X; Li Y; Cao X; Cheng H; Li Y; Li C; Kong Q; Mao Q; Peng P; Ni Y; Li J; Duan Y; Liu L; Ding Z
Theranostics; 2020; 10(19):8573-8590. PubMed ID: 32754264
[No Abstract] [Full Text] [Related]
31. The miR-200 family as prognostic markers in clear cell renal cell carcinoma.
Saleeb R; Kim SS; Ding Q; Scorilas A; Lin S; Khella HW; Boulos C; Ibrahim G; Yousef GM
Urol Oncol; 2019 Dec; 37(12):955-963. PubMed ID: 31635993
[TBL] [Abstract][Full Text] [Related]
32. Quantitative analysis of gene expressions of vascular endothelial growth factor-related factors and their receptors in renal cell carcinoma.
Tsuchiya N; Sato K; Akao T; Kakinuma H; Sasaki R; Shimoda N; Satoh S; Habuchi T; Ogawa O; Kato T
Tohoku J Exp Med; 2001 Oct; 195(2):101-13. PubMed ID: 11846206
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of immunohistochemical staining for myoferlin in clear cell renal cell carcinoma and its association with epidermal growth factor receptor expression.
Jung M; Lee C; Park JH; Moon KC
Urol Oncol; 2019 Nov; 37(11):812.e9-812.e16. PubMed ID: 31421995
[TBL] [Abstract][Full Text] [Related]
34. Proteolysis of MOB1 by the ubiquitin ligase praja2 attenuates Hippo signalling and supports glioblastoma growth.
Lignitto L; Arcella A; Sepe M; Rinaldi L; Delle Donne R; Gallo A; Stefan E; Bachmann VA; Oliva MA; Tiziana Storlazzi C; L'Abbate A; Brunetti A; Gargiulo S; Gramanzini M; Insabato L; Garbi C; Gottesman ME; Feliciello A
Nat Commun; 2013; 4():1822. PubMed ID: 23652010
[TBL] [Abstract][Full Text] [Related]
35. Regulation of receptor for activated C kinase 1 protein by the von Hippel-Lindau tumor suppressor in IGF-I-induced renal carcinoma cell invasiveness.
He X; Wang J; Messing EM; Wu G
Oncogene; 2011 Feb; 30(5):535-47. PubMed ID: 20871634
[TBL] [Abstract][Full Text] [Related]
36. Proliferating cell nuclear antigen and epidermal growth factor receptor (EGFr) status in renal cell carcinoma patients with polysomy of chromosome 7.
Amare Kadam PS; Varghese C; Bharde SH; Narasimhamoorthy NK; Desai S; Advani SH; Havaldar R; Kulkarni JN
Cancer Genet Cytogenet; 2001 Mar; 125(2):139-46. PubMed ID: 11369057
[TBL] [Abstract][Full Text] [Related]
37. Micropeptide MIAC inhibits the tumor progression by interacting with AQP2 and inhibiting EREG/EGFR signaling in renal cell carcinoma.
Li M; Liu G; Jin X; Guo H; Setrerrahmane S; Xu X; Li T; Lin Y; Xu H
Mol Cancer; 2022 Sep; 21(1):181. PubMed ID: 36117171
[TBL] [Abstract][Full Text] [Related]
38. LDLR promotes growth and invasion in renal cell carcinoma and activates the EGFR pathway.
Zhang GM; Chen W; Yao Y; Luo L; Sun LJ
Neoplasma; 2022 Jan; 69(1):113-122. PubMed ID: 34846158
[TBL] [Abstract][Full Text] [Related]
39. MiR-483-5p downregulation contributed to cell proliferation, metastasis, and inflammation of clear cell renal cell carcinoma.
Wang XG; Zhu YW; Wang T; Chen B; Xing JC; Xiao W
Kaohsiung J Med Sci; 2021 Mar; 37(3):192-199. PubMed ID: 33151036
[TBL] [Abstract][Full Text] [Related]
40. CRISPR-mediated ablation of overexpressed EGFR in combination with sunitinib significantly suppresses renal cell carcinoma proliferation.
Liu B; Diaz Arguello OA; Chen D; Chen S; Saber A; Haisma HJ
PLoS One; 2020; 15(5):e0232985. PubMed ID: 32413049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
